SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-13-421136
Filing Date
2013-10-31
Accepted
2013-10-31 17:08:51
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d619225ds3.htm S-3 372571
2 EX-5.1 d619225dex51.htm EX-5.1 4230
3 EX-23.2 d619225dex232.htm EX-23.2 1678
4 EX-23.3 d619225dex233.htm EX-23.3 1754
5 GRAPHIC g619225g27v53.jpg GRAPHIC 9019
6 GRAPHIC g619225g47u79.jpg GRAPHIC 13279
  Complete submission text file 0001193125-13-421136.txt   412373
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-192025 | Film No.: 131183497
SIC: 8731 Services-Commercial Physical & Biological Research